drugset / Trial / NCT02837328
Magnesium Supplementation for the Prevention of Supraventricular Arrhythmias
RandomizedParallel-groupTriple-blindPrevention
Summary
The primary objective of this research is to determine whether oral magnesium supplementation in healthy, community-living individuals will be associated with reductions in the burden of arrhythmias in the upper chambers of the heart (supraventricular arrhythmias).
Timeline
- Start
- 2017-03-01
- Primary completion
- 2017-09-15
- Completion
- 2017-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Magnesium Citrate | Unknown | 400 mg | Oral |